Overview
Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke
Status:
Completed
Completed
Trial end date:
2015-05-01
2015-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate the efficacy and safety of HC-58 in patients with severe upper limb hemiplegia following stroke.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Asahi Kasei Pharma Corporation
Criteria
Inclusion Criteria:- Patients with severe upper limb hemiplegia after stroke
- Within 28 days after stroke at enrollment
Exclusion Criteria:
- Patients with sensory loss between shoulder and hand on paralyzed side
- Patients with pain between shoulder and hand on paralysed side which affects medical
rehabilitation